v3.26.1
Fair Value Measurements - Summary of Financial Assets Recognized at Fair Value on Recurring Basis (Detail) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Marketable securities:    
Investment in Kyverna Therapeutics, Inc. $ 10,459 $ 11,034
Fair Value on Recurring Basis [Member]    
Assets    
Cash equivalents and restricted cash equivalents 78,641 92,263
Marketable securities:    
Total marketable securities 522,226 449,670
Investment in Kyverna Therapeutics, Inc. 10,459 11,034
Total Assets 611,326 552,967
Fair Value on Recurring Basis [Member] | U.S. Treasury and Other Government - Backed Securities [Member]    
Marketable securities:    
Total marketable securities 275,645 221,117
Fair Value on Recurring Basis [Member] | Financial Institution Debt Securities [Member]    
Marketable securities:    
Total marketable securities 168,784 146,815
Fair Value on Recurring Basis [Member] | Corporate Debt Securities [Member]    
Marketable securities:    
Total marketable securities 77,797 81,738
Fair Value on Recurring Basis [Member] | Level 1 [Member]    
Assets    
Cash equivalents and restricted cash equivalents 78,641 92,263
Marketable securities:    
Total marketable securities 184,124 150,852
Investment in Kyverna Therapeutics, Inc. 10,459 11,034
Total Assets 273,224 254,149
Fair Value on Recurring Basis [Member] | Level 1 [Member] | U.S. Treasury and Other Government - Backed Securities [Member]    
Marketable securities:    
Total marketable securities 184,124 150,852
Fair Value on Recurring Basis [Member] | Level 2 [Member]    
Marketable securities:    
Total marketable securities 338,102 298,818
Total Assets 338,102 298,818
Fair Value on Recurring Basis [Member] | Level 2 [Member] | U.S. Treasury and Other Government - Backed Securities [Member]    
Marketable securities:    
Total marketable securities 91,521 70,265
Fair Value on Recurring Basis [Member] | Level 2 [Member] | Financial Institution Debt Securities [Member]    
Marketable securities:    
Total marketable securities 168,784 146,815
Fair Value on Recurring Basis [Member] | Level 2 [Member] | Corporate Debt Securities [Member]    
Marketable securities:    
Total marketable securities $ 77,797 $ 81,738